See more : Praj Industries Limited (PRAJIND.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Enzo Biochem, Inc. (ENZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Enzo Biochem, Inc., a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- ForgeRock, Inc. (FORG) Income Statement Analysis – Financial Results
- Zhejiang Xinao Textiles Inc. (603889.SS) Income Statement Analysis – Financial Results
- Shalimar Paints Limited (SHALPAINTS.NS) Income Statement Analysis – Financial Results
- Bengal & Assam Company Limited (BENGALASM.BO) Income Statement Analysis – Financial Results
- Suzhou Shihua New Material Technology Co., Ltd. (688093.SS) Income Statement Analysis – Financial Results
Enzo Biochem, Inc. (ENZ)
About Enzo Biochem, Inc.
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products segment develops, manufactures, and markets products and tools to clinical research, drug development, and bioscience research customers. It offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also provides its products to scientific experts in the fields of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment provides molecular and other clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. It operates a full-service clinical laboratory in Farmingdale, New York; a network of 30 patient service centers in New York and New Jersey; and a free-standing 'STAT' or rapid response laboratories in New York City and Connecticut, as well as a full-service phlebotomy center and an in-house logistics department. The Therapeutics segment develops novel approaches in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases. It markets its products and services through its direct sales force and a network of distributors in the United States and internationally. The company was founded in 1976 and is headquartered in New York, New York.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 31.91M | 31.06M | 107.07M | 117.73M | 76.02M | 81.17M | 104.71M | 107.80M | 102.77M | 97.60M | 95.95M | 93.71M | 103.08M | 102.03M | 97.08M | 89.57M | 77.80M | 52.91M | 39.83M | 43.40M | 41.64M | 52.77M | 54.02M | 58.41M | 50.03M | 44.30M | 40.40M | 34.90M | 34.50M | 31.70M | 22.80M | 20.00M | 20.50M | 19.80M | 19.40M | 12.10M | 9.10M | 8.70M | 7.30M |
| Cost of Revenue | 17.28M | 19.50M | 65.10M | 64.15M | 52.25M | 57.92M | 60.39M | 59.48M | 57.19M | 54.77M | 54.27M | 54.84M | 55.97M | 53.82M | 52.12M | 53.06M | 40.22M | 23.23M | 16.09M | 14.74M | 13.10M | 11.78M | 10.85M | 17.42M | 14.10M | 14.30M | 13.80M | 13.80M | 13.60M | 12.10M | 9.30M | 6.70M | 6.20M | 21.20M | 5.20M | 3.60M | 1.90M | 1.70M | 1.40M |
| Gross Profit | 14.63M | 11.57M | 41.97M | 53.58M | 23.77M | 23.25M | 44.33M | 48.33M | 45.58M | 42.83M | 41.68M | 38.87M | 47.11M | 48.21M | 44.97M | 36.51M | 37.57M | 29.68M | 23.74M | 28.66M | 28.54M | 40.99M | 43.17M | 40.98M | 35.93M | 30.00M | 26.60M | 21.10M | 20.90M | 19.60M | 13.50M | 13.30M | 14.30M | -1.40M | 14.20M | 8.50M | 7.20M | 7.00M | 5.90M |
| Gross Profit Ratio | 45.86% | 37.24% | 39.20% | 45.51% | 31.27% | 28.64% | 42.33% | 44.83% | 44.35% | 43.88% | 43.44% | 41.48% | 45.70% | 47.25% | 46.32% | 40.76% | 48.30% | 56.09% | 59.60% | 66.03% | 68.53% | 77.67% | 79.92% | 70.17% | 71.81% | 67.72% | 65.84% | 60.46% | 60.58% | 61.83% | 59.21% | 66.50% | 69.76% | -7.07% | 73.20% | 70.25% | 79.12% | 80.46% | 80.82% |
| Research & Development | 2.64M | 3.90M | 3.77M | 3.25M | 4.45M | 3.18M | 3.21M | 2.93M | 3.52M | 3.35M | 3.14M | 3.89M | 6.29M | 7.81M | 9.70M | 9.22M | 8.64M | 9.39M | 7.90M | 8.45M | 8.08M | 8.31M | 6.18M | 6.08M | 5.43M | 4.40M | 4.00M | 3.60M | 3.10M | 2.40M | 1.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 24.36M | 27.20M | 53.71M | 44.91M | 49.69M | 44.27M | 44.47M | 44.01M | 43.59M | 41.07M | 41.80M | 43.65M | 51.65M | 48.90M | 52.09M | 45.51M | 43.72M | 41.25M | 35.99M | 30.51M | 32.69M | 28.30M | 28.00M | 25.67M | 23.49M | 20.40M | 19.90M | 16.00M | 17.50M | 17.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | -2.63M | 345.00K | 577.00K | 400.00K | 437.00K | 374.00K | 580.00K | 649.00K | 601.00K | 556.00K | 440.00K | 302.00K | 237.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 21.72M | 27.20M | 53.71M | 44.91M | 42.96M | 44.27M | 44.47M | 44.01M | 43.59M | 41.07M | 41.80M | 43.65M | 51.65M | 48.90M | 52.09M | 45.51M | 43.72M | 41.25M | 35.99M | 30.51M | 32.69M | 28.30M | 28.00M | 25.67M | 23.49M | 20.40M | 19.90M | 16.00M | 17.50M | 17.10M | 10.60M | 16.90M | 12.90M | 0.00 | 15.80M | 12.20M | 9.60M | 9.60M | 4.50M |
| Other Expenses | 0.00 | 380.00K | -1.19M | 6.91M | 488.00K | 382.00K | 168.00K | 125.00K | 122.00K | 95.00K | 194.00K | 5.00K | 5.10M | 4.43M | 3.48M | 5.84M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.93M | 1.90M | 1.90M | 1.80M | 1.80M | 1.80M | 1.50M | 1.50M | 700.00K | 1.20M | 500.00K | 300.00K | 0.00 | 500.00K | 300.00K |
| Operating Expenses | 27.00M | 31.11M | 57.47M | 48.16M | 47.41M | 47.44M | 51.37M | 49.71M | 49.45M | 46.70M | 48.01M | 52.04M | 63.05M | 61.14M | 65.28M | 60.57M | 52.36M | 50.64M | 43.89M | 38.96M | 40.77M | 36.61M | 34.18M | 31.75M | 30.84M | 26.70M | 25.80M | 21.40M | 22.40M | 21.30M | 13.90M | 18.40M | 13.60M | 1.20M | 16.30M | 12.50M | 10.10M | 10.10M | 4.80M |
| Cost & Expenses | 44.27M | 50.60M | 122.58M | 112.31M | 99.66M | 105.36M | 111.75M | 109.19M | 106.64M | 101.48M | 102.27M | 106.87M | 119.02M | 114.96M | 117.39M | 113.63M | 92.58M | 73.87M | 59.98M | 53.71M | 53.88M | 48.40M | 45.03M | 49.18M | 44.94M | 41.00M | 39.60M | 35.20M | 36.00M | 33.40M | 23.20M | 25.10M | 19.80M | 22.40M | 21.50M | 16.10M | 12.00M | 11.80M | 6.20M |
| Interest Income | 3.54M | 0.00 | 178.00K | 8.00K | 454.00K | 1.06M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 581.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 197.00K | 0.00 | 159.00K | 0.00 | 0.00 | 0.00 | 9.78M | 2.58M | 0.00 | 0.00 | 7.14M | 11.52M | 49.99M | 0.00 | 3.92M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 12.00M | 0.00 | 0.00 | 2.70M | 1.60M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 1.27M | 2.68M | 2.83M | 2.65M | 2.78M | 3.04M | 3.13M | 3.60M | 3.84M | 3.79M | 3.97M | 4.61M | 4.48M | 4.47M | 4.27M | 3.46M | 2.15M | 1.19M | 1.12M | 2.33M | 2.36M | 1.81M | 2.15M | 2.25M | 1.93M | 1.90M | 1.90M | 1.80M | 1.80M | 1.80M | 1.50M | 1.50M | 700.00K | 1.20M | 500.00K | 300.00K | 500.00K | 500.00K | 300.00K |
| EBITDA | -8.35M | -20.94M | -15.01M | 3.35M | -27.59M | -24.16M | -3.91M | 1.09M | -6.56M | -1.21M | -5.73M | -14.29M | -11.46M | -8.35M | -17.99M | -20.02M | -8.75M | -19.78M | -19.03M | -7.97M | -9.87M | 6.18M | 11.14M | 11.48M | 7.01M | 5.20M | 2.70M | 1.50M | 300.00K | 100.00K | 1.10M | -3.60M | 1.40M | -1.40M | -1.60M | -3.70M | -2.40M | -2.60M | 1.40M |
| EBITDA Ratio | -26.16% | -39.01% | -10.23% | 10.64% | -19.78% | 100.00% | 100.00% | 100.00% | 100.00% | -1.87% | 1.26% | -3.02% | 13.14% | -8.38% | -14.50% | -22.99% | -16.50% | -42.48% | -47.78% | -50.63% | -23.70% | 11.71% | 20.63% | 19.66% | 14.01% | 11.74% | 1.98% | -0.86% | 18.26% | -35.65% | -6.14% | -13.00% | 8.78% | 16.67% | -19.59% | -61.16% | -59.34% | -67.82% | -9.59% |
| Operating Income | -9.82M | -24.74M | -15.51M | 9.88M | -23.64M | 78.13M | -12.16M | -3.07M | 47.00M | -1.21M | -10.18M | -18.98M | -40.48M | -12.93M | -22.06M | -24.06M | -14.79M | -20.97M | -20.15M | -10.31M | -12.23M | 4.37M | 8.99M | 9.23M | 5.08M | 3.30M | 800.00K | -300.00K | -1.50M | -1.70M | -400.00K | -5.10M | 700.00K | -2.60M | -2.10M | -4.00M | -2.90M | -3.10M | 1.10M |
| Operating Income Ratio | -30.77% | -79.64% | -14.48% | 8.39% | -31.09% | 96.26% | -11.62% | -2.84% | 45.73% | -1.24% | -10.61% | -20.25% | -39.27% | -12.67% | -22.72% | -26.86% | -19.01% | -39.63% | -50.60% | -23.74% | -29.37% | 8.28% | 16.64% | 15.80% | 10.16% | 7.45% | 1.98% | -0.86% | -4.35% | -5.36% | -1.75% | -25.50% | 3.41% | -13.13% | -10.82% | -33.06% | -31.87% | -35.63% | 15.07% |
| Total Other Income/Expenses | 0.00 | -286.00K | -3.31M | 7.18M | 1.85M | 29.68M | 746.00K | 644.00K | 56.92M | -1.09M | 275.00K | 31.00K | -442.00K | 105.00K | -203.00K | -70.00K | 3.89M | 7.79M | 3.14M | 15.52M | 1.15M | 1.36M | 1.35M | 3.00M | 2.58M | 2.10M | 1.80M | 1.90M | -6.00M | 11.40M | 2.60M | -1.20M | -1.80M | 2.60M | -1.80M | 0.00 | 3.00M | -500.00K | 1.00M |
| Income Before Tax | -9.82M | -25.02M | -18.26M | 7.88M | -28.52M | 2.49M | -11.42M | -2.42M | 46.52M | -2.29M | -9.91M | -18.95M | -40.92M | -12.82M | -22.26M | -23.48M | -10.89M | -13.18M | -17.01M | 5.22M | -11.08M | 5.73M | 10.34M | 12.23M | 7.67M | 5.40M | 2.60M | 1.60M | -7.50M | 9.70M | 2.20M | -6.30M | -1.10M | -2.60M | -3.90M | -4.00M | 100.00K | -3.60M | 2.10M |
| Income Before Tax Ratio | -30.77% | -80.56% | -17.06% | 6.69% | -37.52% | 3.07% | -10.90% | -2.25% | 45.26% | -2.35% | -10.32% | -20.22% | -39.70% | -12.57% | -22.93% | -26.21% | -14.00% | -24.90% | -42.71% | 12.02% | -26.61% | 10.85% | 19.14% | 20.94% | 15.33% | 12.19% | 6.44% | 4.58% | -21.74% | 30.60% | 9.65% | -31.50% | -5.37% | -13.13% | -20.10% | -33.06% | 1.10% | -41.38% | 28.77% |
| Income Tax Expense | 0.00 | 12.30M | 4.32M | 4.45M | 5.37M | 101.27M | -1.10M | 82.00K | 1.23M | -7.00K | 72.00K | -712.00K | -1.65M | 137.00K | -28.00K | -87.00K | -239.00K | 85.00K | -1.34M | 2.21M | -4.85M | 1.88M | 3.42M | 5.42M | 1.04M | -1.10M | -800.00K | 100.00K | 200.00K | 4.10M | -2.90M | 100.00K | 100.00K | 12.90M | 200.00K | 100.00K | 600.00K | -2.00M | 600.00K |
| Net Income | -26.08M | 20.29M | -22.58M | 3.43M | -33.89M | -98.78M | -10.32M | -2.50M | 45.29M | -2.29M | -9.98M | -18.24M | -39.27M | -12.96M | -22.23M | -23.56M | -10.65M | -13.26M | -15.67M | 3.00M | -6.23M | 3.84M | 6.92M | 6.81M | 6.62M | 6.50M | 3.40M | 1.50M | -7.70M | 5.60M | 5.30M | -6.90M | -600.00K | -10.80M | -4.10M | -4.10M | -3.50M | -1.60M | 1.50M |
| Net Income Ratio | -81.73% | 65.32% | -21.09% | 2.91% | -44.58% | -121.70% | -9.86% | -2.32% | 44.06% | -2.34% | -10.40% | -19.46% | -38.09% | -12.70% | -22.90% | -26.31% | -13.69% | -25.06% | -39.34% | 6.92% | -14.96% | 7.28% | 12.82% | 11.66% | 13.24% | 14.67% | 8.42% | 4.30% | -22.32% | 17.67% | 23.25% | -34.50% | -2.93% | -54.55% | -21.13% | -33.88% | -38.46% | -18.39% | 20.55% |
| EPS | -0.51 | -1.27 | -0.46 | 0.07 | -0.71 | -2.09 | -0.22 | -0.05 | 0.98 | -0.05 | -0.23 | -0.46 | -1.01 | -0.34 | -0.59 | -0.63 | -0.29 | -0.38 | -0.49 | 0.09 | -0.20 | 0.11 | 0.22 | 0.22 | 0.22 | 0.21 | 0.12 | 0.05 | -0.27 | 0.19 | 0.19 | -0.29 | -0.03 | -0.71 | -0.26 | -0.27 | -0.24 | -0.11 | 0.09 |
| EPS Diluted | -0.51 | -1.27 | -0.46 | 0.07 | -0.71 | -2.08 | -0.22 | -0.05 | 0.97 | -0.05 | -0.23 | -0.46 | -1.01 | -0.34 | -0.59 | -0.63 | -0.29 | -0.38 | -0.49 | 0.09 | -0.20 | 0.11 | 0.22 | 0.21 | 0.20 | 0.21 | 0.11 | 0.05 | -0.27 | 0.19 | 0.18 | -0.29 | -0.03 | -0.71 | -0.26 | -0.27 | -0.24 | -0.11 | 0.09 |
| Weighted Avg Shares Out | 50.90M | 49.16M | 48.59M | 48.19M | 47.70M | 47.35M | 46.91M | 46.35M | 46.15M | 45.36M | 42.56M | 39.61M | 38.80M | 38.36M | 38.00M | 37.51M | 36.88M | 35.02M | 32.22M | 32.10M | 31.70M | 32.97M | 31.36M | 31.25M | 30.79M | 30.31M | 29.97M | 29.47M | 28.84M | 29.38M | 28.05M | 24.00M | 18.26M | 15.29M | 15.60M | 15.13M | 14.69M | 14.98M | 16.60M |
| Weighted Avg Shares Out (Dil) | 50.90M | 49.16M | 48.59M | 48.33M | 47.70M | 47.48M | 46.97M | 46.35M | 46.60M | 45.36M | 42.56M | 39.61M | 38.80M | 38.36M | 38.00M | 37.51M | 36.88M | 35.02M | 32.22M | 32.76M | 31.70M | 33.78M | 32.33M | 32.56M | 32.80M | 30.97M | 31.29M | 29.47M | 28.91M | 29.38M | 29.33M | 24.00M | 18.26M | 15.29M | 15.60M | 15.13M | 14.69M | 14.98M | 16.60M |
Enzo Biochem Reports First Quarter Fiscal 2021 Financial Results and Provides Business Update
Enzo Biochem to Report First Quarter 2021 Financial Results on Wednesday, December 9
ENZO BIOCHEM ANNOUNCES APPOINTMENT OF IAN B. WALTERS, MD, TO ITS BOARD OF DIRECTORS
ENZO BIOCHEM ANNOUNCES APPOINTMENT OF MARY TAGLIAFERRI, MD, TO ITS BOARD OF DIRECTORS
ENZO BIOCHEM LAUNCHES GOTESTMENOW™ ONLINE PLATFORM FOR CONSUMERS TO DIRECTLY ORDER COVID-19 LABORATORY TESTS
Mid-Afternoon Market Update: Dow Tumbles Over 100 Points; Allscripts Healthcare Solutions Shares Jump
Enzo Biochem Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
ENZO BIOCHEM TO PROVIDE ACCESS TO COVID-19 TESTING AT MORE THAN 50 NY PHARMACIES IN COLLABORATION WITH CPESN NY
Source: https://incomestatements.info
Category: Stock Reports